Clinical trials: Rokitansky Kuster Hauser Syndrome
Mayer Rokitansky Kuster Hauser Syndrome
Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome
In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly.
- Trial name
- MRKH (NCT02967822)
- Testing
- Biological samples for patients, Biological samples for healthy relatives
- Where
- 2 sites in France
- Volunteers
- 410 people, healthy volunteers welcome
- Sponsor
- Imagine Institute
Mayer Rokitansky Kuster Hauser Syndrome, Müllerian Agenesis
Clinical and Imaging Features in MRKH Syndrome
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a congenital condition characterized by uterovaginal agenesis in phenotypically normal women with a 46,XX karyotype.
- Trial name
- ROK-US (NCT07321782)
- Where
- Italy
- Volunteers
- 25 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS